{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T12:39:11Z","timestamp":1788439151034,"version":"build-2803163510"},"reference-count":113,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"am","delay-in-days":307,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006751","name":"U.S. Army","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009898","name":"Defense Health Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009898","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ajem.2024.11.073","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T02:51:12Z","timestamp":1732589472000},"page":"172-179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["An emergency medicine review: Multiple myeloma and its complications"],"prefix":"10.1016","volume":"88","author":[{"given":"Brit","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arleigh","family":"McCurdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Koyfman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajem.2024.11.073_bb0005","author":"International Myeloma Foundation"},{"key":"10.1016\/j.ajem.2024.11.073_bb0010","author":"SEER Stat Fact Sheets: Myeloma"},{"issue":"10272","key":"10.1016\/j.ajem.2024.11.073_bb0015","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0140-6736(21)00135-5","article-title":"Multiple myeloma","volume":"397","author":"van de Donk","year":"2021","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ajem.2024.11.073_bb0020","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/ajh.26590","article-title":"Multiple myeloma: 2022 update on diagnosis, risk stratification, and management","volume":"97","author":"Rajkumar","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ajem.2024.11.073_bb0025","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International myeloma working group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ajem.2024.11.073_bb0030","first-page":"33","article-title":"Differential diagnosis and therapeutic advances in multiple myeloma: a review article","volume":"13","author":"Hussain","year":"2023","journal-title":"Blood Lymphat Cancer"},{"issue":"6","key":"10.1016\/j.ajem.2024.11.073_bb0035","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.hoc.2014.08.010","article-title":"Multiple myeloma","volume":"28","author":"Holstein","year":"2014","journal-title":"Hematol Oncol Clin North Am"},{"issue":"5","key":"10.1016\/j.ajem.2024.11.073_bb0040","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/jama.2022.0003","article-title":"Diagnosis and management of multiple myeloma: a review","volume":"327","author":"Cowan","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.ajem.2024.11.073_bb0045","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1001\/jamaoncol.2018.2128","article-title":"Global burden of multiple myeloma: a systematic analysis for the Global Burden of Disease Study 2016","volume":"4","author":"Cowan","year":"2018","journal-title":"JAMA Oncol"},{"issue":"6","key":"10.1016\/j.ajem.2024.11.073_bb0050","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/ajh.25764","article-title":"Treatment and disease-related complications in multiple myeloma: implications for survivorship","volume":"95","author":"Chakraborty","year":"2020","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.ajem.2024.11.073_bb0055","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma","volume":"78","author":"Kyle","year":"2003","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.ajem.2024.11.073_bb0060","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.hoc.2007.08.006","article-title":"Complications of multiple myeloma","volume":"21","author":"Blad\u00e9","year":"2007","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.ajem.2024.11.073_bb0065","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1182\/blood-2008-12-194241","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study","volume":"113","author":"Landgren","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ajem.2024.11.073_bb0070","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1002\/cncr.20652","article-title":"Incidence of multiple myeloma in Olmsted County, Minnesota: trend over 6 decades","volume":"101","author":"Kyle","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ajem.2024.11.073_bb0075","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajem.2024.11.073_bb0080","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1182\/asheducation-2010.1.295","article-title":"Monoclonal gammopathy of undetermined significance and smoldering myeloma: new insights into pathophysiology and epidemiology","volume":"2010","author":"Landgren","year":"2010","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.ajem.2024.11.073_bb0085","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1038\/leu.2009.134","article-title":"Patterns of monoclonal gammopathy of undetermined significance and multiple myeloma in various ethnic\/racial groups: support for genetic factors in pathogenesis","volume":"23","author":"Landgren","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.ajem.2024.11.073_bb0090","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1182\/blood-2010-07-298760","article-title":"Racial disparities in incidence and outcome in multiple myeloma: a population-based study","volume":"116","author":"Waxman","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ajem.2024.11.073_bb0095","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/bjh.12562","article-title":"Incidence of haematological malignancies by ethnic group in England, 2001-7","volume":"163","author":"Shirley","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ajem.2024.11.073_bb0100","first-page":"202","article-title":"Cancer statistics for African American\/Black People 2022","volume":"72","author":"Giaquinto","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajem.2024.11.073_bb0105","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1056\/NEJMsr1606602","article-title":"Body fatness and cancer--viewpoint of the IARC Working Group","volume":"375","author":"Lauby-Secretan","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajem.2024.11.073_bb0110","article-title":"Adiposity and cancer at major anatomical sites: umbrella review of the literature","volume":"356","author":"Kyrgiou","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.ajem.2024.11.073_bb0115","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1001\/jamaoncol.2018.5639","article-title":"Proportion of cancer cases attributable to excess body weight by US state, 2011-2015","volume":"5","author":"Islami","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ajem.2024.11.073_bb0120","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/s41416-022-01907-2","article-title":"Anthropometric traits and risk of multiple myeloma: a pooled prospective analysis","volume":"127","author":"Bertrand","year":"2022","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajem.2024.11.073_bb0125","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.clml.2019.11.014","article-title":"Effect of exposure to agent orange on the risk of monoclonal gammopathy and subsequent transformation to multiple myeloma: a single-center experience from the veterans affairs hospital","volume":"20","author":"Bumma","year":"2020","journal-title":"Detroit Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.ajem.2024.11.073_bb0130","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3109\/10428199809057562","article-title":"Multiple myeloma in young patients: clinical presentation and treatment approach","volume":"30","author":"Blad\u00e9","year":"1998","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1016\/j.ajem.2024.11.073_bb0135","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/bjh.14513","article-title":"Multiple myeloma: routes to diagnosis, clinical characteristics and survival - findings from a UK population-based study","volume":"177","author":"Howell","year":"2017","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.ajem.2024.11.073_bb0140","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/ajh.24351","article-title":"Central nervous system involvement by multiple myeloma: a multi-institutional retrospective study of 172 patients in daily clinical practice","volume":"91","author":"Jurczyszyn","year":"2016","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.ajem.2024.11.073_bb0145","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.emc.2018.04.009","article-title":"Emergency medicine evaluation and management of anemia","volume":"36","author":"Long","year":"2018","journal-title":"Emerg Med Clin North Am"},{"key":"10.1016\/j.ajem.2024.11.073_bb0150","first-page":"272","article-title":"Initial treatment of multiple myeloma: long-term results in 914 patients","volume":"2","author":"Blade","year":"2001","journal-title":"Hematol J"},{"key":"10.1016\/j.ajem.2024.11.073_bb0155","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/0002-9343(62)90262-0","article-title":"Studies of the anemia of multiple myeloma","volume":"33","author":"Cline","year":"1962","journal-title":"Am J Med"},{"key":"10.1016\/j.ajem.2024.11.073_bb0160","series-title":"StatPearls [Internet]","article-title":"Hyperviscosity syndrome. [Updated 2023 Mar 13]","author":"Perez Rogers","year":"2024"},{"key":"10.1016\/j.ajem.2024.11.073_bb0165","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/ki.1995.421","article-title":"Acute myeloma kidney","volume":"48","author":"Winearls","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajem.2024.11.073_bb0170","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1001\/archinte.1990.00040031693017","article-title":"Renal failure in multiple myeloma. Pathogenesis and prognostic implications","volume":"150","author":"Alexanian","year":"1990","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ajem.2024.11.073_bb0175","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/archinte.158.17.1889","article-title":"Renal failure in multiple myeloma. Presenting features and predictors of outcome in a series of 94 patients","volume":"158","author":"Blade","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ajem.2024.11.073_bb0180","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0272-6386(83)80075-4","article-title":"Renal lesions in multiple myeloma: their relationship to associated protein abnormalities","volume":"4","author":"Hill","year":"1983","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ajem.2024.11.073_bb0185","first-page":"484","article-title":"Pathogenesis and treatment of myeloma kidney","volume":"124","author":"Sanders","year":"1994","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.ajem.2024.11.073_bb0190","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1200\/JCO.1994.12.11.2398","article-title":"Immunoglobulin D multiple myeloma: presenting features, response to therapy, and survival in a series of 83 patients","volume":"12","author":"Blade","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajem.2024.11.073_bb0195","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1182\/blood-2003-10-3400","article-title":"Acquired Fanconi syndrome is an indolent disorder in the absence of overt multiple myeloma","volume":"104","author":"Ma","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ajem.2024.11.073_bb0200","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1001\/archinte.1982.00340250041008","article-title":"Reversible renal insufficiency in multiple myeloma","volume":"142","author":"Bernstein","year":"1982","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ajem.2024.11.073_bb0205","first-page":"147","article-title":"Renal failure in multiple myeloma: a study of the presenting findings, response to treatment, and prognosis in 26 patients","volume":"28","author":"Cavo","year":"1986","journal-title":"Nouv Rev Fr Hematol"},{"key":"10.1016\/j.ajem.2024.11.073_bb0210","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0002-9343(84)90781-2","article-title":"Acute renal failure in patients with multiple myeloma","volume":"76","author":"Cohen","year":"1984","journal-title":"Am J Med"},{"key":"10.1016\/j.ajem.2024.11.073_bb0215","first-page":"903","article-title":"Chronic dialysis in patients with multiple myeloma and renal failure: a worthwhile treatment","volume":"270","author":"Iggo","year":"1989","journal-title":"Q J Med"},{"key":"10.1016\/j.ajem.2024.11.073_bb0220","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0272-6386(12)81021-3","article-title":"The role of continuous ambulatory peritoneal dialysis in end-stage renal failure due to multiple myeloma","volume":"6","author":"Korzets","year":"1990","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ajem.2024.11.073_bb0225","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/j.1365-2141.1995.tb05400.x","article-title":"Patients with multiple myeloma and renal failure requiring long-term dialysis: presenting features, response to therapy, and outcome in a series of 20 cases","volume":"91","author":"Torra","year":"1995","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.ajem.2024.11.073_bb0230","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jemermed.2018.04.004","article-title":"Controversies in management of hyperkalemia","volume":"55","author":"Long","year":"2018","journal-title":"J Emerg Med"},{"issue":"16","key":"10.1016\/j.ajem.2024.11.073_bb0235","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2022.18331","article-title":"Hypercalcemia: a review","volume":"328","author":"Walker","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.ajem.2024.11.073_bb0240","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.935821","article-title":"A review of current clinical concepts in the pathophysiology, etiology, diagnosis, and management of hypercalcemia","volume":"28","author":"Tonon","year":"2022","journal-title":"Med Sci Monit"},{"issue":"5","key":"10.1016\/j.ajem.2024.11.073_bb0245","article-title":"Hypercalcemia of malignancy complicated by osteonecrosis of the jaw treated with cinacalcet","volume":"1","author":"Vasquez","year":"2023","journal-title":"JCEM Case Rep"},{"key":"10.1016\/j.ajem.2024.11.073_bb0250","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1086\/605664","article-title":"Infections in patients with multiple myeloma in the era of high-dose therapy and novel agents","volume":"49","author":"Nucci","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajem.2024.11.073_bb0255","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3324\/haematol.2014.107714","article-title":"Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients","volume":"100","author":"Blimark","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.ajem.2024.11.073_bb0260","doi-asserted-by":"crossref","first-page":"9219","DOI":"10.1200\/JCO.2005.03.2086","article-title":"Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United kingdom Medical Research Council trials between 1980 and 2002--Medical Research Council Adult Leukaemia Working Party","volume":"23","author":"Augustson","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajem.2024.11.073_bb0265","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1080\/10428190500472503","article-title":"Immune parameters in multiple myeloma patients: influence of treatment and correlation with opportunistic infections","volume":"47","author":"Sch\u00fctt","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ajem.2024.11.073_bb0270","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/s12879-016-1648-2","article-title":"Epidemiology of invasive pneumococcal infections: manifestations, incidence and case fatality rate correlated to age, gender and risk factors","volume":"16","author":"Backhaus","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ajem.2024.11.073_bb0275","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2141.1983.tb02021.x","article-title":"Abnormal monoclonal antibody-defined helper\/suppressor T-cell subpopulations in multiple myeloma: relationship to treatment and clinical stage","volume":"53","author":"Mills","year":"1983","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ajem.2024.11.073_bb0280","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1046\/j.1365-2249.2001.01582.x","article-title":"Deregulated cytokine network and defective Th1 immune response in multiple myeloma","volume":"125","author":"Frassanito","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ajem.2024.11.073_bb0285","doi-asserted-by":"crossref","first-page":"553","DOI":"10.4049\/jimmunol.167.1.553","article-title":"Suppression of IL-2-induced T cell proliferation and phosphorylation of STAT3 and STAT5 by tumor-derived TGF beta is reversed by IL-15","volume":"167","author":"Campbell","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.ajem.2024.11.073_bb0290","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/bjh.13532","article-title":"Risks, severity and timing of infections in patients with multiple myeloma: a longitudinal cohort study in the era of immunomodulatory drug therapy","volume":"171","author":"Teh","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ajem.2024.11.073_bb0295","first-page":"1901","article-title":"Risks and burden of viral respiratory tract infections in patients with multiple myeloma in the era of immunomodulatory drugs and bortezomib: experience at an Australian Cancer Hospital","volume":"23","author":"Teh","year":"2015","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ajem.2024.11.073_bb0300","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.bbmt.2012.06.008","article-title":"Cytomegalovirus reactivation following autologous peripheral blood stem cell transplantation for multiple myeloma in the era of novel chemotherapeutics and tandem transplantation","volume":"18","author":"Kim","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.ajem.2024.11.073_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0308463","article-title":"Risk assessment and clinical implications of COVID-19 in multiple myeloma patients: a systematic review and meta-analysis","volume":"19","author":"Mahmud","year":"2024","journal-title":"PloS One"},{"key":"10.1016\/j.ajem.2024.11.073_bb0310","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1093\/jac\/dkw157","article-title":"ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients","volume":"71","author":"Maertens","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajem.2024.11.073_bb0315","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciq147","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.ajem.2024.11.073_bb0320","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.3390\/jcm12093188","article-title":"2023 update on sepsis and septic shock in adult patients: management in the emergency department","volume":"12","author":"Guarino","year":"2023","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.ajem.2024.11.073_bb0325","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jemermed.2016.07.102","article-title":"Clinical mimics: an emergency medicine-focused review of sepsis mimics","volume":"52","author":"Long","year":"2017","journal-title":"J Emerg Med"},{"issue":"9","key":"10.1016\/j.ajem.2024.11.073_bb0330","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.3390\/microorganisms11092231","article-title":"Management of sepsis and septic shock: what have we learned in the last two decades?","volume":"11","author":"Kamath","year":"2023","journal-title":"Microorganisms"},{"issue":"4","key":"10.1016\/j.ajem.2024.11.073_bb0335","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jemermed.2016.10.008","article-title":"Practical considerations in sepsis resuscitation","volume":"52","author":"Long","year":"2017","journal-title":"J Emerg Med"},{"issue":"1","key":"10.1016\/j.ajem.2024.11.073_bb0340","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.emc.2016.09.004","article-title":"Ready for prime time? Biomarkers in sepsis","volume":"35","author":"Long","year":"2017","journal-title":"Emerg Med Clin North Am"},{"issue":"11","key":"10.1016\/j.ajem.2024.11.073_bb0345","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"issue":"10","key":"10.1016\/j.ajem.2024.11.073_bb0350","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/j.ajem.2020.06.083","article-title":"Clostridioides difficile infection evaluation and management in the emergency department","volume":"38","author":"Carius","year":"2020","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ajem.2024.11.073_bb0355","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ajem.2022.12.042","article-title":"High risk and low prevalence diseases: adult bacterial meningitis","volume":"65","author":"Pajor","year":"2023","journal-title":"Am J Emerg Med"},{"issue":"9","key":"10.1016\/j.ajem.2024.11.073_bb0360","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/j.ajem.2018.06.074","article-title":"Infectious endocarditis: an update for emergency clinicians","volume":"36","author":"Long","year":"2018","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ajem.2024.11.073_bb0365","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ajem.2022.01.008","article-title":"High risk and low prevalence diseases: spinal epidural abscess","volume":"53","author":"Long","year":"2022","journal-title":"Am J Emerg Med"},{"issue":"7","key":"10.1016\/j.ajem.2024.11.073_bb0370","doi-asserted-by":"crossref","first-page":"410","DOI":"10.5435\/00124635-201107000-00004","article-title":"Multiple myeloma: diagnosis and orthopaedic implications","volume":"19","author":"Scharschmidt","year":"2011","journal-title":"J Am Acad Orthop Surg"},{"issue":"3","key":"10.1016\/j.ajem.2024.11.073_bb0375","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1359\/JBMR.041131","article-title":"Fracture risk with multiple myeloma: a population-based study","volume":"20","author":"Melton","year":"2005","journal-title":"J Bone Miner Res"},{"issue":"7","key":"10.1016\/j.ajem.2024.11.073_bb0380","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1148\/rg.2018180073","article-title":"Imaging features and management of stress, atypical, and pathologic fractures","volume":"38","author":"Marshall","year":"2018","journal-title":"Radiographics"},{"key":"10.1016\/j.ajem.2024.11.073_bb0385","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0025-7125(16)30865-3","article-title":"Back pain and epidural spinal cord compression","volume":"71","author":"Posner","year":"1987","journal-title":"Med Clin North Am"},{"issue":"1","key":"10.1016\/j.ajem.2024.11.073_bb0390","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ajem.2019.158402","article-title":"Evaluation and management of cauda equina syndrome in the emergency department","volume":"38","author":"Long","year":"2020","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ajem.2024.11.073_bb0395","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/brain\/123.4.710","article-title":"Long term prognosis of neuropathy associated with antiMAG IgM M-proteins and its relationship to immune therapies","volume":"123","author":"Nobile-Orazio","year":"2000","journal-title":"Brain"},{"issue":"Suppl. 2","key":"10.1016\/j.ajem.2024.11.073_bb0400","article-title":"Therapy of neuropathy associated with antiMAG IgM monoclonal gammopathy with Rituxan","volume":"52","author":"Latov","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.ajem.2024.11.073_bb0405","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1212\/WNL.52.8.1701","article-title":"IgM antibody related polyneuropathies: B-cell depletion chemotherapy using rituximab","volume":"52","author":"Levine","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.ajem.2024.11.073_bb0410","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/10428190310001597964","article-title":"Myeloma of the central nervous system: strong association with unfavorable chromosomal abnormalities and other high-risk disease features","volume":"45","author":"Fassas","year":"2004","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1016\/j.ajem.2024.11.073_bb0415","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12245-023-00540-x","article-title":"Diagnosis and management of elevated intracranial pressure in the emergency department","volume":"16","author":"Patel","year":"2023","journal-title":"Int J Emerg Med"},{"key":"10.1016\/j.ajem.2024.11.073_bb0420","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/(SICI)1096-8652(199912)62:4<228::AID-AJH5>3.0.CO;2-3","article-title":"Cerebral and meningeal multiple myeloma after autologous stem cell transplantation. A case report and review of the literature","volume":"62","author":"Petersen","year":"1999","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ajem.2024.11.073_bb0425","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1001\/archneur.61.9.1423","article-title":"Multiple myeloma invasion of the central nervous system","volume":"61","author":"Schluterman","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ajem.2024.11.073_bb0430","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2141.2004.05199.x","article-title":"Multiple myeloma involving central nervous system: high frequency of chromosome 17p13.1 (p53) deletions","volume":"127","author":"Chang","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ajem.2024.11.073_bb0435","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1002\/cncr.23330","article-title":"Myelomatous meningitis","volume":"112","author":"Chamberlain","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.ajem.2024.11.073_bb0440","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/bjh.12404","article-title":"Central nervous system multiple myeloma--potential roles for intrathecal therapy and measurement of cerebrospinal fluid light chains","volume":"162","author":"Lee","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ajem.2024.11.073_bb0445","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1056\/NEJM200205233462119","article-title":"Hyperammonemic encephalopathy in multiple myeloma","volume":"346","author":"Kwan","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajem.2024.11.073_bb0450","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0925-5710(95)00359-Z","article-title":"Serum amino acid disturbance in multiple myeloma with hyperammonemia","volume":"61","author":"Matsuzaki","year":"1995","journal-title":"Int J Hematol"},{"key":"10.1016\/j.ajem.2024.11.073_bb0455","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/ajh.20808","article-title":"Hyperammonemia and encephalopathy in patients with multiple myeloma","volume":"82","author":"Talamo","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ajem.2024.11.073_bb0460","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/sj.leu.2401077","article-title":"In vitro excess ammonia production in human myeloma cell lines","volume":"12","author":"Otsuki","year":"1998","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.ajem.2024.11.073_bb0465","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/bjh.14058","article-title":"The influence of baseline characteristics and disease stage on health-related quality of life in multiple myeloma: findings from six randomized controlled trials","volume":"174","author":"Robinson","year":"2016","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.ajem.2024.11.073_bb0470","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2017.4519","article-title":"Carfilzomib-associated cardiovascular adverse events: a systematic review and meta-analysis","volume":"4","author":"Waxman","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ajem.2024.11.073_bb0475","first-page":"JCO1900231","article-title":"Prospective study of cardiac events during proteasome inhibitor therapy for relapsed multiple myeloma","author":"Cornell","year":"2019","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"7","key":"10.1016\/j.ajem.2024.11.073_bb0480","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1001\/jamaoncol.2016.3350","article-title":"Cardiovascular and thrombotic complications of novel multiple myeloma therapies: a review","volume":"3","author":"Li","year":"2017","journal-title":"JAMA Oncol"},{"issue":"24","key":"10.1016\/j.ajem.2024.11.073_bb0485","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1182\/blood-2009-11-252072","article-title":"Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study","volume":"115","author":"Kristinsson","year":"2010","journal-title":"Blood"},{"issue":"25","key":"10.1016\/j.ajem.2024.11.073_bb0490","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1056\/NEJM200106213442516","article-title":"Deep venous thrombosis and thalidomide therapy for multiple myeloma","volume":"344","author":"Osman","year":"2001","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ajem.2024.11.073_bb0495","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/cncr.23336","article-title":"Thromboembolic events with lenalidomide-based therapy for multiple myeloma","volume":"112","author":"Menon","year":"2008","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ajem.2024.11.073_bb0500","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/sj.leu.2405062","article-title":"Prevention of thalidomide- and lenalidomide- associated thrombosis in myeloma","volume":"22","author":"Palumbo","year":"2008","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.ajem.2024.11.073_bb0505","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archinte.160.6.809","article-title":"Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study","volume":"160","author":"Heit","year":"2000","journal-title":"Arch Intern Med"},{"issue":"Suppl. 1","key":"10.1016\/j.ajem.2024.11.073_bb0510","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1182\/blood-2018-99-110567","article-title":"The HAS-RISC score for venous thromboembolism (VTE) risk stratification in newly diagnosed multiple myeloma patients starting immunomodulatory drugs (IMID)","volume":"132","author":"Li","year":"2018","journal-title":"Blood"},{"issue":"15_suppl","key":"10.1016\/j.ajem.2024.11.073_bb0515","doi-asserted-by":"crossref","first-page":"6585","DOI":"10.1200\/JCO.2018.36.15_suppl.6585","article-title":"Prediction of venous thromboembolism (VTE) in multiple myeloma (MM): myeloma clot score (MCS)","volume":"36","author":"Sanfilippo","year":"2018","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ajem.2024.11.073_bb0520","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(09)70284-0","article-title":"Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial","volume":"11","author":"Rajkumar","year":"2010","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.ajem.2024.11.073_bb0525","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJMoa1411321","article-title":"Carfilzomib, lenalidomide, and dexamethasone for relapsed multiple myeloma","volume":"372","author":"Stewart","year":"2015","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ajem.2024.11.073_bb0530","doi-asserted-by":"crossref","first-page":"840","DOI":"10.6004\/jnccn.2018.7273","article-title":"Derivation and validation of a risk assessment model for immunomodulatory drug-associated thrombosis among patients with multiple myeloma","volume":"17","author":"Li","year":"2019","journal-title":"J Nat Comprehens Cancer Network: JNCCN"},{"issue":"3","key":"10.1016\/j.ajem.2024.11.073_bb0535","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.annemergmed.2023.01.019","article-title":"Managing pulmonary embolism","volume":"82","author":"Westafer","year":"2023","journal-title":"Ann Emerg Med"},{"issue":"10","key":"10.1016\/j.ajem.2024.11.073_bb0540","doi-asserted-by":"crossref","first-page":"E202","DOI":"10.1002\/ajh.24118","article-title":"The characterization of adrenal insufficiency and identification of its risk factors in patients with plasma cell dyscrasias","volume":"90","author":"Tremblay","year":"2015","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.ajem.2024.11.073_bb0545","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jemermed.2022.06.005","article-title":"Diagnosis and management of adrenal insufficiency and adrenal crisis in the emergency department","volume":"63","author":"Lentz","year":"2022","journal-title":"J Emerg Med"},{"issue":"4","key":"10.1016\/j.ajem.2024.11.073_bb0550","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.emc.2023.06.005","article-title":"Thyrotoxicosis","volume":"41","author":"Inman","year":"2023","journal-title":"Emerg Med Clin North Am"},{"key":"10.1016\/j.ajem.2024.11.073_bb0555","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ajem.2020.09.062","article-title":"Decompensated hypothyroidism: a review for the emergency clinician","volume":"39","author":"Bridwell","year":"2021","journal-title":"Am J Emerg Med"},{"issue":"21","key":"10.1016\/j.ajem.2024.11.073_bb0560","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1182\/blood.V122.21.3233.3233","article-title":"Combination of lenalidomide, dexamethasone and cyclophosphamide as treatment for the first relapse of multiple myeloma: efficacy, toxicity and occurance of thyroid abnormalities","volume":"122","author":"Adam","year":"2013","journal-title":"Blood"},{"issue":"1 Suppl","key":"10.1016\/j.ajem.2024.11.073_bb0565","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bbmt.2008.10.009","article-title":"Late effects after autologous hematopoietic cell transplantation","volume":"15","author":"Burns","year":"2009","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675724006600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675724006600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:27:51Z","timestamp":1762309671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675724006600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":113,"alternative-id":["S0735675724006600"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2024.11.073","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An emergency medicine review: Multiple myeloma and its complications","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2024.11.073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}